HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Osthoff Selected Research

Interstitial Lung Diseases (Interstitial Lung Disease)

1/2020Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
1/2019Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Osthoff Research Topics

Disease

14Infections
01/2022 - 08/2010
6COVID-19
11/2021 - 01/2020
6Sepsis (Septicemia)
01/2021 - 01/2013
5Mannose-Binding Protein Deficiency
08/2014 - 08/2010
4Bacteremia
01/2021 - 04/2016
4Disease Progression
01/2021 - 08/2014
3Communicable Diseases (Infectious Diseases)
01/2021 - 10/2019
3Critical Illness (Critically Ill)
01/2021 - 01/2016
3Reperfusion Injury
01/2019 - 09/2012
2Chronic Renal Insufficiency
01/2022 - 01/2021
2Pneumonia (Pneumonitis)
01/2022 - 01/2021
2Inflammation (Inflammations)
01/2022 - 01/2020
2Fever (Fevers)
01/2021 - 06/2019
2Acute Lung Injury
01/2021 - 01/2021
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020 - 01/2019
2Systemic Scleroderma (Systemic Sclerosis)
01/2019 - 11/2014
2Virus Diseases (Viral Diseases)
11/2018 - 08/2010
2Ischemia
01/2013 - 01/2011
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2012 - 09/2009
1Hyperuricemia
01/2022
1Epstein-Barr Virus Infections
01/2022
1Gout
01/2022
1Candidemia
10/2021
1Chronic Obstructive Pulmonary Disease (COPD)
08/2021
1IgG Deficiency
08/2021
1Anemia
01/2021
1Chills
01/2021
1Pain (Aches)
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Hypercalcemia (Milk Alkali Syndrome)
01/2021
1Renal Insufficiency (Renal Failure)
01/2021
1Multiple Myeloma
01/2021
1Pneumococcal Infections
01/2021
1Cough
01/2021
1Obesity
01/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1Lung Diseases (Lung Disease)
01/2021
1Hypersensitivity (Allergy)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Tuberculosis (Tuberculoses)
01/2021
1Soft Tissue Infections
01/2021
1Peripheral Arterial Disease
01/2021
1Abdominal Pain (Pain, Abdominal)
05/2020
1Liver Abscess
05/2020
1Gastrointestinal Hemorrhage (Hematochezia)
05/2020
1Abscess
05/2020
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Idiopathic Pulmonary Fibrosis
01/2020
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020
1Sarcoidosis (Schaumann Disease)
01/2020

Drug/Important Bio-Agent (IBA)

12Complement System Proteins (Complement)IBA
01/2021 - 01/2011
10Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 05/2015
10Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
08/2021 - 08/2010
10LectinsIBA
01/2020 - 01/2013
6Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2013
5Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
01/2021 - 01/2018
4Pharmaceutical PreparationsIBA
10/2021 - 01/2016
3AutoantibodiesIBA
01/2019 - 09/2009
2AntibodiesIBA
11/2021 - 11/2012
2EpitopesIBA
11/2021 - 11/2012
2AntigensIBA
11/2021 - 01/2021
2C-Reactive ProteinIBA
01/2021 - 01/2020
2conestat alfaIBA
01/2021 - 01/2020
2EnzymesIBA
01/2020 - 11/2012
2Pattern Recognition ReceptorsIBA
01/2020 - 08/2014
2Cystatin CIBA
01/2020 - 09/2012
2Interferon LambdaIBA
11/2018 - 08/2014
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2017 - 04/2016
2LactamsIBA
01/2017 - 01/2016
1Uric Acid (Urate)IBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
08/2021
1GlucocorticoidsIBA
08/2021
1Antiviral Agents (Antivirals)IBA
05/2021
1Clarithromycin (Biaxin)FDA LinkGeneric
01/2021
1AlbuminsIBA
01/2021
1Complement Inactivating AgentsIBA
01/2021
1tocilizumab (atlizumab)FDA Link
01/2021
1Investigational DrugsIBA
01/2021
1Alkaline PhosphataseIBA
01/2021
1Floxacillin (Flucloxacillin)IBA
01/2021
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2021
1VancomycinFDA LinkGeneric
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Goserelin (Zoladex)FDA Link
01/2021
1Prostate-Specific Antigen (Semenogelase)IBA
01/2021
1Cytochrome P-450 CYP3AIBA
01/2020
1NeopterinIBA
01/2020
1LopinavirFDA Link
01/2020

Therapy/Procedure

9Therapeutics
01/2022 - 04/2016
2Duration of Therapy
08/2021 - 09/2019
2Critical Care (Surgical Intensive Care)
01/2021 - 03/2016
1Length of Stay
01/2022
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Contraindications
01/2021
1Noninvasive Ventilation
01/2021
1Punctures
05/2020
1Patient Readmission
04/2020